Company intelligence
MyEyeDr.
See the possible
About MyEyeDr.
MyEyeDr. empowers our patients to live their best lives by providing comprehensive eye care and an expansive selection of eye wear solutions. Our trusted community of doctors and team members make personalized vision healthcare accessible for everyone. Together, we are committed to giving the gift of great vision, helping our patients see and do more. Co-founded by Sue Downes in 2001, we’ve grown to more than 1,000 offices across 28 states. Alongside our exponential growth, our employees have built meaningful careers helping patients see and look their best.
Verified activity
Signals from MyEyeDr.
10 published signals
People
MyEyeDr. is hiring for Optometrist and Extern openings across Florida, Georgia, and South Carolina.
Reported by Samantha Sikes
Presence & Recognition
MyEyeDr. featured ZEN AI Co. in its ZEN Agent Daily Briefing for September 8, 2026.
Reported by Alexander L.
Presence & Recognition
MyEyeDr. announced that ZEN AI Co. published a ZEN Agent Daily Briefing for September 7, 2026.
Reported by Alexander L.
Research & Knowledge
MyEyeDr. noted that Eli Lilly struck a $2.9B deal for Merida Biosciences precision antibody platform.
Reported by Alexander L.
Research & Knowledge
MyEyeDr. announced that Revolution Medicines scored breakthrough FDA approval for pancreatic cancer drug Rasonque.
Reported by Alexander L.
Presence & Recognition
MyEyeDr. announced that ZEN AI Co. provided the latest developments for the Zen Agent Daily Briefing on September 3, 2026.
Reported by Alexander L.
Research & Knowledge
MyEyeDr. published new data from Prevent Blindness showing that more than 44,000 sports-related eye injuries were treated in 2025.
Reported by Sue Downes
Research & Knowledge
MyEyeDr. Merck and Moderna scored a Phase 3 win for cancer vaccine plus Keytruda in melanoma.
Reported by Alexander L.
Research & Knowledge
MyEyeDr. Eli Lilly acquired Merida Biosciences for up to $2.875B in immunology.
Reported by Alexander L.
Research & Knowledge
MyEyeDr. Vara earned a world-first CE certification for autonomous AI breast cancer screening.
Reported by Alexander L.